False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. by Cresci, Barbara et al.
ORIGINAL ARTICLE
False and true pre-treatment predictors of weight loss in obese
patients starting a program for lifestyle change
Barbara Cresci • Laura Pala • Roberta Poggiali •
Cosetta Guarnieri • Edoardo Mannucci •
Michela Bigiarini • Carlo Maria Rotella
Received: 16 January 2014 / Accepted: 10 April 2014 / Published online: 11 May 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Purpose Weight loss treatment effectiveness and cost-
effectiveness may be improved by the identification of
patients who are more prone to participate and gain benefit
from specific interventions. Aim of the present study is to
identify easily available additional predictors of weight
loss among data usually present in the medical records of
obese/overweight patients attending an outpatient clinic for
a non-pharmacological lifestyle change program.
Results 268 patients, 74 men and 195 women (age
43.2 ± 11.9 years, BMI 38.9 ± 6.8 kg/m2) were enrolled.
Among these patients, only 35.6 % men and 22.7 %
women completed the 6-month protocol. Among partici-
pants, 50.7 % lost at least 5 % initial body weight after
6 months (SUCCESSES), while 49.3 % failed (FAIL-
URES). Baseline nutritional parameters (total Kcal, lipid,
carbohydrate, protein and alcohol intake) were not signif-
icantly different in successes when compared to failures,
while a significant difference between groups was observed
for baseline diastolic blood pressure (DBP); free fat mass
(FFM); muscle mass (MM); total body water (TBW); HDL
cholesterol; ALT; AST; cGT. After dividing into quartiles
the not-normally distributed variables, successes had AST
values above median (3rd and 4th quartiles; v2 = 0.003).
At multivariate analysis (linear regression), the OR was
3.34 (1.42–7.85; p = 0.006).
Conclusions In our patients, baseline liver enzyme levels
(AST in particular), but not baseline quantitative and
qualitative dietary intake, were significantly different in
successes versus failures and could therefore represent a
predictor of success. In conclusion, AST could represent a
usually available biomarker that could be used as a pre-
dictor of outcome (weight loss) in obese patients starting a
lifestyle change program.
Keywords Obesity  Outcome  Muscle mass  Weight
loss
Introduction
Weight loss programs for obese patients, particularly those
lifestyle change-oriented and without any pharmacological
treatment, are known to be time consuming and usually
show low percentages of success in terms of weight loss for
a relevant number of different reasons [1]. At this purpose,
weight loss treatment effectiveness and cost-effectiveness
may be improved, not only by the identification of factors
affecting weight loss, but mainly by the identification of
patients who are sufficiently motivated and thus more able
to participate and gain benefit from the intervention.
Many parameters have been identified with a potential
capacity of predicting success/failure in a weight loss
program [2–4]. Among these, the most suggestive could be
considered: self-motivation [5–7]; self-efficacy [8]; active
lifestyle [9]; more relevant initial weight loss [10]; social
and/or family support [11, 12].
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Our group has already explored this area, reporting that
therapeutic success is predicted by basal TRE-MORE test
scores and by estimated muscle mass. In fact, we have
found that a higher muscle mass, as estimated through
bioimpedance analysis (BIA), is associated with a greater
weight loss in obese patients [13]. Moreover, we demon-
strated that therapeutic success is predicted by TRE-MORE
test scores. In particular, TRE-MORE total score is a pre-
dictor of failure, but not of attendance, whereas drop-out
patients showed a lower score only in TREMORE-3 sub-
scale which investigates lifestyle habits [14, 15].
A substantial body of literature exists suggesting that
weight loss can be achieved by varying the macronutrient
distribution and composition of dietary factors. Champagne
et al. [16] have investigated the effect of dietary intake
modifications on weight loss and maintenance during an
intensive behavioral weight loss program, concluding that
success was mainly associated with increased intake of
proteins, fruits and vegetables, and low-fat dairy. More-
over, many studies have explored the possibility of using
the variation in the intake of different macronutrients as
predictors of weight loss [17–19]. Very few studies, on the
contrary, explore pre-treatment dietary habits impact on
treatment success. Recently, Byrne et al. [20] evaluated the
effects of pre-treatment self-efficacy for diet and exercise,
as well as changes in self-efficacy occurring during treat-
ment, on weight loss success, demonstrating that treatment
attendance and changes in exercise self-efficacy during
treatment were stronger predictors of weight loss than
changes in diet.
It is well known that obesity is frequently associated to
many other morbidities. The majority of these complica-
tions are related to comorbid conditions that include cor-
onary artery disease, hypertension, type 2 diabetes mellitus,
respiratory disorders and dyslipidemia. Therefore, patients
starting a weight loss program are usually screened for
biohumoral parameters related to these complications, such
as lipid profile, glycemia, insulinemia, blood pressure
levels and liver function, the potentiality of which as pre-
dictors has not yet been demonstrated.
Aim of the present study is to identify easily available
predictors that could be used as additional predictors of
weight loss among data present in the medical records of
obese/overweight patients attending an outpatient clinic.
Methods
Patients
The study was carried out in the Outpatient Clinic of the
Obesity Agency of the University of Florence. Complete
baseline data including blood samples results were
collected for 268 patients out of the enrolled 331 seeking
treatment for overweight/obesity in our outpatient clinic
[15].
Inclusion and exclusion criteria are shown in Table 1.
Before the collection of data, during the first routine
visit, the procedures of the study were fully explained; after
that, the patients were asked to provide their written
informed consent to the participation to the study. The
study protocol had been previously approved by the Local
Ethical Committee. The treatment protocol was carried out
as previously described [15].
Measurements
At baseline, an Endocrinologist collected an accurate
medical history, performed a complete physical examina-
tion and measured anthropometric parameters (BMI, waist
circumference, blood pressure and heart rate). Body fat
(BF) and lean body mass were estimated through BIA,
performed by a tetrapolar single frequency (50 kHz) phase-
sensitive impedance analyzer (QUANTUM/S; AkernSrl,
Firenze, Italy). In the same day, the patients also met a
dietician (R.P. and C.G.) who assessed usual food intake on
the basis of a 30-day recall, using a dedicated software
(Gedip by Solutions S.n.c, Italy), together with photo atlas
for the determination of portions (Scotti-Bassani Institute,
Italy). A goal of a 500 kcal/day reduction from usual food
intake was agreed upon with the patient. To reach that
objective, the patients were asked to self-monitor their food
intake for at least a week before each monthly follow-up
Table 1 Inclusion and exclusion criteria of patients
Inclusion criteria (A)
Obesity or overweight (BMI C 27 kg/m2)
Age 18–65
Residence within 40 km from the Clinic
Informed consent
Exclusion criteria (B)
Patients living at distances more than 40 km
Uncontrolled endocrine disorders, such as hypo- or
hyperthyroidism
Diabetes
Pregnancy
Illiteracy, or inadequate knowledge of the Italian language
Any condition interfering with the possibility of regular physical
exercise (e.g., severe cardiac dysfunction, severe respiratory
insufficiency, major neurologic disorders, etc.)
Diagnosis of major depression, bipolar disorder, obsessive–
compulsive disorder, schizophrenia, or mental retardation
Current treatment with antipsychotics, antiepileptics, tricyclic
antidepressants, or lithium
Intention to move more than 40 km far from Florence in the
following 12 months
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visit with the dietitian [15]. Blood samples were drawn
after 12-h overnight fast for glucose (Beckman instru-
ments, Fullerton, CA, USA), TSH (Electrochemilumines-
cent, Modular Roche, Milan, Italy), transaminases, gamma-
GT, insulin (electrochemiluminescence immunoassay,
Roche Diagnostics, Mannheim, Germany), cholesterol,
HDL-cholesterol, triglycerides (for lipid panel: Abbott
Bichromatic Analyser (Abbott Diagnostics, South Pasa-
dena, CA, USA). All laboratory determinations were per-
formed in the central Laboratory of Careggi Hospital in
Florence.
Final measures, including BMI and waist, were con-
sidered those collected after 6 months from the enrollment
in the protocol.
Definition of outcomes
Therapeutic success was defined as a weight loss at
6 months of at least 5 % from baseline to assess this
outcome.
Statistical analysis
Continuous variables were reported as mean ± standard
deviations (SD), whereas categorical variables were
reported as median and limits of confidence. Between-
group comparisons of continuous variables were performed
using unpaired Student’s t test or Mann–Whitney U test,
for variables with normal or non-normal distribution,
respectively. Correlation analyses were performed with
Spearman’s method. Logistic regression analyses were
applied for dichotomous outcomes (successes vs. failures).
All analyses were performed using SPSS for Windows
15.0 (Chicago Inc, USA).
Results
268 patients, 74 men and 195 women (age 43.2 ± 11.9
years, weight 105.6 ± 22.6 kg, BMI 38.9 ± 6.8 kg/m2,
waist 116.1 ± 16.2 cm) were enrolled. Among these
patients, only 26 (35.6 %) men and 44 (22.7 %) women
completed the 6-month protocol. Among participants,
50.7 % (n = 70) lost at least 5 % initial body weight after
6 months (and will be thereafter called SUCCESSES),
while 49.3 % (n = 68) failed (FAILURES).
Baseline nutritional parameters, assessed as previously
described, were also analyzed (Table 2). In particular, total
Kcal intake, lipid intake, carbohydrate intake, protein
intake, together with baseline alcohol intake were not
significantly different in successes when compared to
failures. Furthermore, the spontaneous difference in total
kcal intake, lipid intake, carbohydrate intake, protein
intake, alcohol intake recorded after 1-week self-monitor-
ing was not significantly different in successes when
compared to failures.
Differences between baseline data of successes (losing
at least 5 % of initial body weight at the intention-to-treat
analysis) and failures (completers losing \5 % of initial
body weight and drop-outs) are summarized in Table 3. A
significant difference was observed only for diastolic blood
pressure (DBP) (78 ± 6 vs. 75 ± 9 mmHg; p = 0.033);
free fat mass (FFM) (62.8 ± 15.1 vs. 57.8 ± 9.3 %;
p = 0.021); muscle mass (MM) (45.2 ± 12.6 vs. 40.6 ±
7.6 %; p = 0.011); total body water (TBW) (46.3 ± 11.1
vs. 42.5 ± 6.7 %; p = 0.016); HDL (44.9 ± 11.9 vs.
50.5 ± 14.8 mg/dl; p = 0.020); ALT (29.6 ± 30.8 vs.
20 ± 5 mg/dl; p = 0.017); AST (40.4 ± 51.2 vs. 25.5 ± 12.3
mg/dl; p = 0.027); cGT (38.6 ± 52.3 vs. 22.2 ± 11.4 mg/dl;
p = 0.019).
None of these differences was retained at multivariate
analysis with only one exception. In fact, after dividing into
quartiles the not-normally distributed variables, it resulted
that successes have AST values above median (3rd and 4th
quartiles; v2 = 0.003), even if a trend was observed for
ALT (3rd and 4th quartiles; v2 = 0.068) and cGT (3rd and
4th quartiles; v2 = 0.074). At multivariate analysis
Table 2 Baseline nutritional parameters: differences between suc-
cesses and failures
Baseline intake Successes Failures p
Kcal 2,265.1 ± 887.4 2,032.7 ± 856.1 0.121
Proteins (g) 88.3 ± 33.8 83.7 ± 31.5 0.513
Lipids (g) 82.1 (68.3–106.1) 81.0 (65.0–102) 0.784
Saturated lipids (g) 25.0 ± 10.4 22.2 ± 12.1 0.228
Carbohydrates (g) 293.8 ± 136.6 253.4 ± 118.2 0.067
Alcohol (g) 5.0 (1.2–23.5) 4.4 (1.0–19.9) 0.511
Data are shown as media ± SD, whereas categorical variables were
reported as median and limits of confidence
Table 3 Differences between baseline data of successes (losing at
least 5 % of initial body weight at the intention-to-treat analysis) and
failures (completers losing \5 % of initial body weight and drop-
outs)
Successes Failures p
DBP (mmHg) 78 ± 6 75 ± 9 0.033
FFM (%) 62.8 ± 15.1 57.8 ± 9.3 0.021
MM (%) 45.2 ± 12.6 40.6 ± 7.6 0.011
TBW (%) 46.3 ± 11.1 42.5 ± 6.7 % 0.021
HDL (mg/dl) 44.9 ± 11.9 50.5 ± 14.8 0.020
ALT (mg/dl) 29.6 ± 30.8 20 ± 5 0.017
AST (mg/dl) 40.4 ± 51.2 25.5 ± 12.3 0.027
cGT (mg/dl) 38.6 ± 52.3 22.2 ± 11.4 0.019
Data are shown as media ± SD
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(logistic regression), after adjusting for age and waist, the
OR for AST was 3.34 (1.42–7.85; p = 0.006).
Discussion
The present study tries to identify new possible predictors
of outcome in a non-pharmacologic lifestyle change-cen-
tered weight loss program. For this purpose, we analyzed a
series of baseline blood parameters, which are usually
studied in obese patients to assess the presence of eventual
comorbidities. In particular, successes resulted to have
GOT/AST values above median.
It is well known that obesity is frequently associated
with a cluster of risk factors including dysglycemia,
hypertension and dyslipidemia, in a few words defined by
the concept of metabolic syndrome (MS). As a conse-
quence, obese patients are often affected by non-alcoholic
fatty liver disease (NAFLD). Impaired hepatic fatty acid
(FA) turnover together with insulin resistance are key
players in NAFLD pathogenesis [21]. Most individuals are
asymptomatic and are usually discovered incidentally
because of abnormal liver function tests. Elevated liver
biochemistry is found in 50 % of patients with simple
steatosis. Change in liver function tests is considered as
surrogate marker of liver injury and non-alcholic fatty liver
disease (NAFLD). Previous studies have demonstrated that
circulating concentration of liver function tests like c-
glutamyltransferase (cGT), alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) is increased
in individuals with insulin resistance and the metabolic
syndrome [22]. In addition, these components of liver
function tests have been shown to be positively associated
with the risk of future type 2 diabetes [23, 24]. In partic-
ular, available data indicate moderate associations of ALT
and cGT with risk of type 2 diabetes events, and no evi-
dence for an increased risk with AST [25, 26].
Moreover, recent data [27] speculate that abnormal
levels of ALT and AST are associated with a deregulation
of normal amino acid metabolism in the liver, including
aromatic amino acid, and then special compounds such as
glutamate are released into the general circulation. This
hypothesis attempts to illustrate the critical role of the
‘‘liver metabolism’’ in the pathogenesis of the MS and
postulates that before the liver becomes fatty, abnormal
levels of liver enzymes might reflect high levels of hepatic
transamination of amino acids in the organ. Anyway, ele-
vated transaminase levels could represent an early at-risk
situation of pre-NAFLD.
In our patients, baseline liver enzyme levels (AST in
particular), but not baseline quantitative (total Kcal) and
qualitative (lipids, carbohydrates, proteins, alcohol) dietary
intake, were significantly different in successes versus
failures and could therefore represent a predictor of suc-
cess. Successes have AST values above median. A possible
explanation could be that AST is raised in acute liver
damage, but is also present in red blood cells, and cardiac
and skeletal muscle and is therefore not specific to the
liver. For instance, in athletes, the interpretation of serum
aminotransferases concentrations should consider the
release of AST from muscle and of ALT mainly from the
liver [28]. Therefore, we could speculate that the predictive
value of AST but not of ALT or cGT in our population
could be related to the significantly different amount of
baseline muscle mass in the two populations. This could be
consistent with our previous findings that successes have
better baseline grade of fitness in terms of initial muscle
mass when compared to failures [15].
Both genetic and environmental factors have been pro-
posed to be involved in the etiology of NAFLD. Thus,
nutrition is reasonably considered to be a potential envi-
ronmental factor affecting the risk for this disease.
Although there is consistent evidence that overweight due
to energy overconsumption increases the risk for and the
prevalence of fatty liver, the role of diet composition, in
terms of macro- or micronutrients, in the pathogenesis of
the disease remains controversial [29]. Dietary habits
shown by patients before starting the lifestyle change
program have not been demonstrated to be significantly
different between those losing at least 5 % of initial body
weight and failures. The same result was obtained com-
paring the basal and 1 week after quantitative and quali-
tative dietary intake, spontaneously modified by patients
without the dietician intervention. Anyway, we should
point out that both baseline total Kcal and carbohydrate
intake, even if not reaching the statistical significance,
show different values when comparing successes and
failures. In particular, failures report lower total Kcal
intake and lower carbohydrate intake before entering the
program. It should be taken into consideration that data
regarding qualitative and quantitative dietary intake were
collected based on information self-reported by patients.
The tools used by the operators, such as a dedicated soft-
ware and a photo atlas representing different portion sizes,
were aimed at reducing the bias, but the problem related to
an altered perception from the patient’s point of view could
nevertheless be still present.
Moreover, despite worldwide guidelines and recom-
mendations, research examining diet composition for the
management of obesity remains controversial. Previous
studies have found that low-fat diets promote short-term
weight loss [30]; however, some studies suggest that low-
carbohydrate, high-protein, and high-fat diets may also
result in substantial weight loss [31]. We can therefore
conclude that a substantial body of literature exists sug-
gesting that weight loss can be achieved by varying the
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macronutrient distribution and composition of dietary fac-
tors, even if evidence for type of diet on long-term weight
maintenance remains debatable [16, 32]. On the other hand,
few data are present regarding quality of eating patterns as
predictors of weight loss. Hart et al. [33] demonstrated that
early changes in eating habits, but not baseline eating
behaviors may promote greater BMI reductions in a cohort of
adolescent patients. These findings are consistent with our
data, even if referred to a completely different population.
Based on our data, we can at the moment conclude that
neither usual dietary habits nor self-management operated
by patients based on personal beliefs could represent a
good predictor of success for this kind of programs.
Finally, these results confirm once again that baseline grade
of fitness (i.e., initial muscle mass) is a better predictor of
success, rather than dietary habits, when starting a lifestyle
modification program, as already demonstrated by our
group [15].
Moreover, we can conclude that AST could represent a
usually available biomarker that could be used as a pre-
dictor of weight loss in obese patients starting a lifestyle
change program. Nevertheless, this should be considered as
a pilot study which includes a reasonable number of
patients and therefore the efficacy of present data, which
aim to identify a weight loss predictor of outcome, will
need to be verified through specifically designed longer-
term randomized clinical trials enrolling a larger number of
patients.
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